Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-23-042628

Chief Financial Officer sold 13,199 shares at $30.00 ($395,970)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bonstein Sara · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-22 Sale : show line 1 in the form 10b5-1 −13,199 $30.00 $395,970 105,241 D
Open-market sales · 13,199 sh · avg $30.00 · $395,970
Loading xslF345X05/wk-form4_1703279004.xml…